Countries India
The Indian Biotechnology industry will reach $150 bn target by 2025.
The Indian Biotechnology industry that was valued at $70 bn in 2020 will reach $150 bn target by 2025. The percentage share of the biotechnology segments ...
May 09, 2021 | Analysis
India - a biotech growth catalyst
India also plays a key role in the global vaccine market, as the leader in the global supply of DPT, BCG, and measles vaccines, and is a key contribut...
May 09, 2021 | Analysis
Indian Covid19 Crisis : 4.01 lakh new cases, 4187 deaths
Tamil Nadu, Karnataka, Kerala, Rajasthan and Bihar announce lockdown to reign in spread of infections. Maharashtra may suspend vaccination dri...
May 09, 2021 | News
India: Daily confirmed cases: how do they compare to other countries?
To compare countries, it is insightful to look at the number of confirmed cases per million people – this is what the chart shows. Keep ...
April 19, 2021 | Analysis
India: What is the daily number of confirmed COVID19 cases?
What is important to note about these case figures? The reported case figures on a given date do not necessarily show the number of new cases on that ...
April 19, 2021 | Analysis
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
